Antibody-mediated inhibition of FXIIa blocks downstream bradykinin generation

J Allergy Clin Immunol. 2018 Oct;142(4):1355-1358. doi: 10.1016/j.jaci.2018.06.014. Epub 2018 Jun 21.

¹ CSL Limited, BIO21 Institute, Parkville, Victoria, Australia.
² Department of Experimental Biomedicine, University Hospital Würzburg and Rudolf Virchow Center for Experimental Biomedicine, University of Würzburg, Würzburg, Germany.
³ Department of Dermatology, Johannes Gutenberg University, Mainz, Germany.
⁴ Walter and Eliza Hall Institute for Medical Research, Parkville, Victoria, Australia; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia.
⁵ Hungarian Angioedema Center, 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
⁶ CSL Behring GmbH Emil-Von-Behring-Straße 76, Marburg, Germany.
⁷ CSL Limited, BIO21 Institute, Parkville, Victoria, Australia. Electronic address: con.panousis@csl.com.au.

No abstract available

Publication types